Picture of AbCellera Biologics logo

ABCL — AbCellera Biologics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

AbCellera Biologics Inc. reports results for the quarter ended June 30 - Earnings Summary

AbCellera Biologics Inc. reports results for the quarter ended June 30 - Earnings Summary
  • AbCellera Biologics Inc. ABCL.OQ reported a quarterly adjusted loss of 18 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -12 cents. The mean expectation of eight analysts for the quarter was for a loss of 14 cents per share. Wall Street expected results to range from -20 cents to -1 cents per share.

  • Revenue fell 76.3% to $4.05 million from a year ago; analysts expected $7.78 million.

  • AbCellera Biologics Inc.'s reported EPS for the quarter was a loss of 18 cents​.

  • The company reported a quarterly loss of $55.43 million.

  • AbCellera Biologics Inc. shares had fallen by 22.4% this quarter and gained 78.1% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts had risen by about 25.4% in the last three months.​

  • In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

  • Wall Street's median 12-month price target for AbCellera Biologics Inc. is $11.00, about 46.2% above its last closing price of $5.92

This summary was machine generated from LSEG data August 5 at 11:57 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Jun. 30 2026

-0.14

-0.18

Missed

Mar. 31 2026

-0.20

-0.14

Beat

Dec. 31 2025

-0.17

-0.03

Beat

Sep. 30 2025

-0.17

-0.19

Missed

Recent news on AbCellera Biologics

See all news